XML 74 R55.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Related Party Transactions (Details)
1 Months Ended 3 Months Ended 12 Months Ended
Feb. 12, 2018
USD ($)
Feb. 11, 2018
USD ($)
Dec. 14, 2017
USD ($)
Nov. 30, 2017
USD ($)
Jan. 31, 2018
USD ($)
Mar. 31, 2018
USD ($)
Dec. 31, 2019
USD ($)
Dec. 31, 2018
USD ($)
Feb. 28, 2019
USD ($)
Related Party Transaction [Line Items]                  
Payments on related party borrowings             $ 0 $ 5,000,000  
Accumulated deficit             213,059,000 123,025,000  
Increase in related party receivable             0 73,690,000  
Deemed distribution to parent               2,000,000  
Contingent royalty obligation payable to Evolus Founders $ 39,700,000           41,200,000 50,200,000  
Contingent promissory note payable to Evolus Founders 16,042,000           17,945,000 16,904,000  
ALPHAEON                  
Related Party Transaction [Line Items]                  
Period available to cure breach     30 days            
Unwinding fee       $ 9,600,000          
ALPHAEON | Majority Shareholder                  
Related Party Transaction [Line Items]                  
Related party transaction amount in period $ 140,688,000 $ 56,275,000       $ 800,000      
Term of service agreement         1 year        
Period of successive renewal of services agreement         1 year        
Period to notify termination to the other party         60 days        
Payments on related party borrowings           5,000,000      
Related party receivable             $ 0 0  
Related party transaction, debt balance multiplier 2.5                
Accumulated deficit   $ 615,000              
Increase in related party receivable         $ 1,051,000        
Related party receivable         $ 73,690,000        
Deemed distribution to parent $ 66,998,000                
ALPHAEON | Chief Executive Officer                  
Related Party Transaction [Line Items]                  
Related party transaction amount in period           $ 24,000      
Evolus, Inc.                  
Related Party Transaction [Line Items]                  
Due to related parties                 $ 1,575,000
Percentage of voting interests acquired (at least)     50.00%            
Evolus, Inc. | Chief Medical Officer                  
Related Party Transaction [Line Items]                  
Due to related parties                 $ 700,000
Evolus, Inc. | SCH                  
Related Party Transaction [Line Items]                  
Related party transaction amount in period $ 55,742,000   $ 20,000,000            
Up-front payment upon obtaining FDA approval     $ 9,200,000            
Period of termination of first commercial sale     10 years            
Selling, general and administrative expenses | ALPHAEON                  
Related Party Transaction [Line Items]                  
Related party transaction amount in period               383,000  
Research and development | ALPHAEON                  
Related Party Transaction [Line Items]                  
Related party transaction amount in period               $ 0